Several studies have provided persuasive evidence that patients with systemic lupus erythematosus (SLE) have an altered cancer risk profile when compared with the general population. SLE patients display a higher risk of certain malignancies (e.g., hematologic, lung), whereas they seem at lower risk of others (e.g., breast cancer). This altered risk is probably explained by multiple factors, including immunosuppressant drugs, susceptibility to certain viruses, genetic factors, clinical factors, race/ethnicity, immune dysregulation, cytokines, and hormonal factors.
|Original language||English (US)|
|Title of host publication||Lahita’s Systemic Lupus Erythematosus|
|Number of pages||16|
|State||Published - Jan 1 2021|
- Systemic lupus erythematosus (SLE)
ASJC Scopus subject areas
- Immunology and Microbiology(all)